Navigation Links
Pioneering research succeeds in producing industrially vital chemical through engineered bacteria
Date:8/26/2009

A team of South Korean scientists have succeeded in engineering the bacterium E. coli to produce the industrial chemical putrescine. The research, published in the journal Biotechnology and Bioengineering, provides a renewable alternative to the production of this important chemical which is traditionally created using fossil fuels.

Putrescine, a four carbon chain diamine, is an important platform chemical with a wide range of applications for the pharmaceutical, agrochemical and chemical industries. It is currently used to synthesize nylon-4,6, a widely used engineering plastic. Currently putrescine is priced at over 1,600 per ton with an estimated demand of 10,000 tons per year, which is expected to grow.

Currently the production of putrescine on an industrial scale relies on chemical synthesis, which requires non-renewable petrochemicals and expensive catalyst systems. This process is highly toxic and flammable with potentially severe repercussions for both the environment and human health. Now the Korean-based team, led by Professor Sang Yup Lee at KAIST, have pioneered the biotechnological production of the chemical using renewable materials.

"For the first time we have developed a metabolically engineered E. coli strain that efficiently produces putrescine," said Professor Lee. "The development of a bio-refinery for chemicals and materials is very important in a world where dependency on fossil fuels is an increasing concern."

The team developed a strain of E.coli capable of producing putrescine through metabolic engineering. This is where a cell's metabolic and regulatory networks are enhanced in order to increase production of a needed product.

First the team weakened or deleted competing metabolic pathways within the E.Coli strain before deleting pathways which cause putrescine degradation. They also amplified the crucial enzyme Spec C, which converts the chemical ornithine into putrescine. Finally th
'/>"/>

Contact: Ben Norman
Benorman@wiley.com
44-012-437-70375
Wiley-Blackwell
Source:Eurekalert

0

GOOD

Page: 1 2

Related biology technology :

1. Georgia Reproductive Specialists is First in Southeast to Offer Pioneering Test of Womens Biological Clock
2. NorthPoint Domain and Boston Medical Center Partner to Apply Advanced Patient Engagement Instruments to Pioneering Cardiac Robotic Surgery Program
3. Pioneering IVF Technique Produces Region's First Pregnancy
4. PAREXEL Expands Pioneering Asian Ethnobridging Expertise
5. Pioneering Cancer Center Introduces Advanced Varian RapidArc(TM) Treatments for Cancer Patients in Central Germany
6. Frost & Sullivan Recognizes Nanopoint for its Pioneering Cell Imaging Solution, the cellTRAY(R) Imaging System CT-2000
7. DNA Software, Inc. Awarded $2.5 M in NIH Funding to Develop Pioneering Nucleic Acid-based Technologies
8. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
9. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
10. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
11. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... 2013  U.S. Secretary of State John Kerry ... Syngenta  scientist Mary-Dell Chilton , Ph.D., was ... Prize. The prize is the foremost international award recognizing ... quality, quantity or availability of food in the world. ... recognized for "revolutionary biotechnology discoveries that unlocked the key ...
(Date:6/19/2013)... -- Continuing its long history of proven clinical performance in ... Inc. announces the U.S. Food and Drug Administration (FDA) ... assay for use on its Access 2 immunoassay system. ... Coulter,s troponin I test for over 12 years ... to continue providing dependability to laboratories supporting emergency care," ...
(Date:6/19/2013)... , June 19, 2013 /PRNewswire/ ... Bureau presents Innovative Drug Delivery ... Technology Licensing Opportunities for Generic ... There are more ... release drugs approved all over ...
(Date:6/19/2013)... MN (PRWEB) June 19, 2013 Express ... abuse tests, today announced that it has received Class ... market and sell its DrugCheck® NxStep Onsite Drug ... use of the rapid screening device in near-patient settings, ... Drug Screen Cup received Health Canada Class III approval ...
Breaking Biology Technology:Syngenta's Mary-Dell Chilton named 2013 World Food Prize laureate 2Beckman Coulter Announces FDA Clearance of New Access AccuTnI+3 Troponin I Assay for the Access 2 Immunoassay System 2Beckman Coulter Announces FDA Clearance of New Access AccuTnI+3 Troponin I Assay for the Access 2 Immunoassay System 3Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies 2Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies 3Express Diagnostics’ DrugCheck® On-site Test Cup Receives Health Canada Class III Medical Device Approval 2Express Diagnostics’ DrugCheck® On-site Test Cup Receives Health Canada Class III Medical Device Approval 3
... CUREXO Technology Corporation, pioneer in medical robotics ... orthopaedic applications, which is focused on marketing its ... be exhibiting at the upcoming American Association of ... Center in Las Vegas, February 25th through the ...
... INDIANAPOLIS, Feb. 23 Heart patients with acute coronary ... a new treatment option to help prevent heart attacks. ... Lilly and Company (NYSE: LLY ) announced ... for EFIENT (R) (pronounced Ef-ee-ent) (prasugrel) ...
... - Misys Learning Suite Adoption Facilitates Best-Of-Breed ... (FTSE: MSY.L), the global application software and services,company, today announces ... Learning Suite to train its expanding workforce as,part of its ... established user of the core banking system Misys Equation, has,elected ...
Cached Biology Technology:CUREXO Technology Corporation Launches Its ROBODOC(R) Surgical System at Upcoming Orthopaedic Conference in Las Vegas 2European Commission Approves EFIENT(R) (prasugrel) for Patients with Acute Coronary Syndrome Undergoing PCI 2European Commission Approves EFIENT(R) (prasugrel) for Patients with Acute Coronary Syndrome Undergoing PCI 3European Commission Approves EFIENT(R) (prasugrel) for Patients with Acute Coronary Syndrome Undergoing PCI 4European Commission Approves EFIENT(R) (prasugrel) for Patients with Acute Coronary Syndrome Undergoing PCI 5Misys Improves Efficiency and Performance at International Bank of Qatar 2
(Date:6/18/2013)... between 5% and 10% of breast and ovarian cancers ... these tumours are attributable to inherited mutations from the ... patients with these mutations, PARP inhibitors, which are currently ... them a new option for personalised cancer treatment, an ... that a fraction of these patients generate resistance to ...
(Date:6/18/2013)... (18 June 2013). A team of internationally recognized feline ... Sarah Ellis from the University of Lincoln, U.K. and ... U.S.A. were invited by the International Society of Feline ... (AAFP) to compile guidelines for veterinarians, owners and those ... needs of the domestic cat. The new guidelines appear ...
(Date:6/17/2013)... the U.S. exposed to high levels of air pollution while ... child with autism as women who lived in areas with ... of Public Health (HSPH). It is the first large national ... the U.S. , "Our findings raise concerns since, depending on ... study lived in areas where risk of autism was elevated," ...
Breaking Biology News(10 mins):An article in 'Cell' reveals a new resistance mechanism to chemotherapy in breast and ovarian cancer 2Feline behavior experts release guidelines to improve the welfare of cats 2Exposure to high pollution levels during pregnancy may increase risk of having child with autism 2
... -- A project by three Bowling Green State University biologists ... of information that will be usable for years to come ... greenhouse gases and lake ecosystems. Drs. George Bullerjahn, Michael ... "dead zones" in Lake Erie was one of only 41 ...
... premier authorities on aging will share the most up-to-date news ... Older Americans Act, and other current topics at The ... Meeting . This event the largest interdisciplinary conference in ... 18 to 22 in Boston. GSA extends complimentary registration ...
... 11, 2011 in the Jim Wise Theatre on the New ... simulcast broadcast available to viewers worldwide. The independently organized ... and will feature young people in the technology field. ... their passion for innovation and entrepreneurship. "The ...
Cached Biology News:BGSU researchers harness power of genome institute for Great Lakes study 2BGSU researchers harness power of genome institute for Great Lakes study 3Register now! Boston meeting will showcase latest aging discoveries 2Register now! Boston meeting will showcase latest aging discoveries 3Live from Newark: TEDxNJIT simulcast on Nov. 11 to viewers worldwide 2
Homo sapiens inhibin, beta B (activin AB beta polypeptide) Antigen: Recombinant Protein(142~254aa)...
Wheat Germ Agglutinin (WGA) PS SPA Imaging Bead, 2 g. Category: Leadseeker Beads....
... 8 micro-bore tubes to 1 outflow Single-cell ... Rapid (several millisecond) solution change Very ... , Solid construction 360, 250 and ... For mounting on any micromanipulator Available in ...
Sf21 cells derived from Spodoptera frugiperda ovarian cells are recommended for high-level production of recombinant proteins. Higher expression levels of some proteins are seen due to the larger ce...
Biology Products: